Ad hoc announcement pursuant to art. 53 SIX Swiss Exchange Listing Rules President Region International, Francisco Ballester, to retire as of March 1, 2025, after 34 years of service Peter Stenico, currently Global Platform Head Biosimilars and Country President Sandoz Austria, concurrently appointed President Region International and a member of the Sandoz Executive Committee Basel, [...]
DECATUR, Ga., Jan. 30, 2025 (Korea Bizwire) – On 30 January 2025, the World Health Organization (WHO) announced that Niger has been verified for eliminating the transmission of onchocerciasis, commonly known as river blindness. The Mectizan Donation Program and Merck, known as MSD outside of the U.S. and Canada, congratulate the government, and the people [...]
VANCOUVER, British Columbia, Jan. 30, 2025 (Korea Bizwire) – Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard of care for difficult-to-treat diseases, including cancer, inflammation, and autoimmune disease, today announced that management will participate in the following upcoming investor conferences: Oppenheimer 35th Annual Healthcare [...]
2024 Revenues of $16.5 billion reflect an increase of 6%, in local currency terms, compared to 2023; AUSTEDO® - exceeding $1.6 billion in revenues, surpassing 2024 outlook; AJOVY® - global annual revenues of $507 million, an increase of 18% in local currency terms compared to 2023; UZEDY® revenues of $117 million in 2024 surpassing $100M outlook; Generics business [...]
WALTHAM, Mass., Jan. 28, 2025 (Korea Bizwire) – Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of transformative immunology-based therapies, today announced management’s fireside chat presentation at the Guggenheim SMID Cap Biotech Conference on Wednesday, February 5, 2025, at [...]
REYKJAVIK, Iceland and PARSIPPANY, N.J., Jan. 27, 2025 (Korea Bizwire) – Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide, and Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA), today announced that the U.S. Food and Drug Administration (FDA) [...]
Egg-quity Index Calls Out Costa Coffee, Best Western, and Dunkin’s Cage-Free Shortcomings HONG KONG, Jan. 27, 2025 (Korea Bizwire) – As the New Year begins and 2025 marks the final countdown for many cage-free egg commitments, Mercy For Animals, in partnership with organisations all over the world, has released the 2024 Egg-quity Index. The Index categorises 29 companies based [...]
NEW YORK, Jan. 24, 2025 (Korea Bizwire) – SoftSmile, Inc., ClearCorrect Operating, LLC, and Institut Straumann AG announce that they have amicably settled all litigation and legal disputes between them. The companies had been engaged in several legal disputes in the United States and Pakistan. About SoftSmile SoftSmile is a New York-based technology company that [...]
LUCERNE, Switzerland, Jan. 21, 2025 (Korea Bizwire) – Neoviva, a leading luxury rehab centre launches Switzerland’s first and only assurance programme in addiction treatment. With a structured and tailored approach, Neoviva’s programme addresses the unique needs of each client, blending cutting-edge therapeutic methods with comprehensive aftercare. The Neoviva Guarantee is a testament to the effectiveness [...]
Ad hoc announcement under Art. 53 LR Baar (Switzerland), 21 January 2025 Based on preliminary unaudited figures, Ascom reports for fiscal year 2024 a revenue of CHF 286.7 million, which is a decline of 1.6% at constant currencies, and an EBITDA margin of around 7.5%. In a continuing challenging market environment, Ascom generated net revenue [...]